Question 0 of 18

Drug Classification  ·  Questions 1–6

Identify the pharmacological class or categorical label for each drug or receptor. Vocabulary preparation is sufficient to answer every question in this section.

Question 1

Nitroglycerin is classified as which type of agent?

  • ABeta-blocker
  • BCalcium channel blocker
  • COrganic nitrate
  • DDiuretic

Correct Answer

C) Organic nitrate

Rationale

Nitroglycerin belongs to the organic nitrate class of antianginal agents.

Question 2

Diltiazem is classified as which type of calcium channel blocker?

  • ANon-dihydropyridine
  • BDihydropyridine
  • CBeta-blocker
  • DOrganic nitrate

Correct Answer

A) Non-dihydropyridine

Rationale

Diltiazem belongs to the non-dihydropyridine class of calcium channel blockers.

Question 3

Nifedipine is classified as which type of calcium channel blocker?

  • ANon-dihydropyridine
  • BOrganic nitrate
  • CBeta-blocker
  • DDihydropyridine

Correct Answer

D) Dihydropyridine

Rationale

Nifedipine belongs to the dihydropyridine class of calcium channel blockers.

Question 4

Metoprolol is classified as which type of agent?

  • ACalcium channel blocker
  • BBeta-blocker
  • COrganic nitrate
  • DAlpha-agonist

Correct Answer

B) Beta-blocker

Rationale

Metoprolol belongs to the beta-blocker class of antianginal agents.

Question 5

Isosorbide dinitrate is classified as which type of agent?

  • ALong-acting organic nitrate
  • BShort-acting organic nitrate
  • CCalcium channel blocker
  • DBeta-blocker

Correct Answer

A) Long-acting organic nitrate

Rationale

Isosorbide dinitrate belongs to the long-acting organic nitrate class of antianginal agents.

Question 6

Verapamil is classified as which type of calcium channel blocker?

  • ADihydropyridine
  • BOrganic nitrate
  • CNon-dihydropyridine
  • DBeta-blocker

Correct Answer

C) Non-dihydropyridine

Rationale

Verapamil belongs to the non-dihydropyridine class of calcium channel blockers.

Core Pharmacology  ·  Questions 7–14

Apply your understanding of drug mechanisms, pharmacokinetics, and adverse effects. Each question requires one reasoning step.

Question 7

In a patient with stable exertional angina, why does chest discomfort occur predictably at the same level of exertion each time?

  • AA fixed coronary stenosis limits supply once demand rises beyond a reproducible threshold
  • BCoronary artery spasm occurs at a reproducible level of sympathetic stimulation
  • CMicrovascular resistance vessels fail to dilate at a fixed level of exertion
  • DDiastolic filling time shortens at a fixed heart rate regardless of exertion

Correct Answer

A) A fixed coronary stenosis limits supply once demand rises beyond a reproducible threshold

Rationale

Because the limiting factor in stable angina is a fixed anatomic narrowing, the same patient reaches the point where oxygen demand outpaces the artery's fixed supply capacity at roughly the same level of exertion every time, producing the reproducible symptom pattern characteristic of this form of angina.

Question 8

Why does the duration of diastole influence myocardial oxygen supply?

  • ACoronary perfusion pressure rises only during ventricular contraction
  • BVentricular wall stress decreases as diastole lengthens
  • CCoronary arteries fill primarily between heartbeats, so the time available during diastole determines how much blood flow can be delivered
  • DMyocardial contractility increases as diastolic filling time lengthens

Correct Answer

C) Coronary arteries fill primarily between heartbeats, so the time available during diastole determines how much blood flow can be delivered

Rationale

Coronary blood flow occurs mainly during diastole rather than during contraction, so a longer diastolic interval allows more time for the coronary vasculature to deliver oxygen to the heart muscle.

Question 9

Why can beta-blockers worsen coronary vasospasm in a patient with vasospastic angina?

  • AThey increase myocardial oxygen demand by raising contractility
  • BBlocking beta-2 receptors removes a normal vasodilatory influence, leaving alpha-1-mediated vasoconstriction unopposed
  • CThey directly stimulate coronary smooth muscle contraction
  • DThey reduce nitric oxide release from the coronary endothelium

Correct Answer

B) Blocking beta-2 receptors removes a normal vasodilatory influence, leaving alpha-1-mediated vasoconstriction unopposed

Rationale

Beta-2 receptor activity normally provides a vasodilatory counterbalance in coronary smooth muscle. When beta-blockade removes this influence, alpha-1-mediated vasoconstriction predominates, which can potentiate spasm. This effect applies to all beta-blockers, including cardioselective agents.

Question 10

Why are calcium channel blockers considered first-line therapy for vasospastic angina?

  • AThey lower myocardial oxygen demand by reducing heart rate
  • BThey increase nitric oxide release from the coronary endothelium
  • CThey block beta-2 receptors to restore vasodilatory tone
  • DThey directly counteract the calcium-mediated smooth muscle hyperreactivity that produces the spasm

Correct Answer

D) They directly counteract the calcium-mediated smooth muscle hyperreactivity that produces the spasm

Rationale

Vasospastic angina results from coronary smooth muscle that has become hyperreactive to vasoconstrictor stimuli through calcium-dependent contraction. Calcium channel blockers act directly on this mechanism, which is why they are the preferred first-line agents for this subtype of angina.

Question 11

Why can coronary angiography appear normal in a patient with microvascular angina despite genuine myocardial ischemia?

  • AThe dysfunction lies in small coronary resistance vessels that are not well visualized by angiography of the major epicardial arteries
  • BThe epicardial arteries are obstructed only during exertion and relax completely at rest
  • CThe ischemia originates from reduced myocardial contractility rather than reduced blood flow
  • DAngiography only detects narrowing caused by coronary spasm, not fixed plaque

Correct Answer

A) The dysfunction lies in small coronary resistance vessels that are not well visualized by angiography of the major epicardial arteries

Rationale

Microvascular angina results from impaired dilation of small coronary resistance vessels rather than disease of the large epicardial arteries that angiography is designed to visualize, which is why the major coronary arteries appear normal even though true ischemia is present.

Question 12

Why is sublingual nitroglycerin generally less effective in microvascular angina than in stable exertional angina?

  • AMicrovascular angina does not involve any reduction in coronary blood flow
  • BNitroglycerin is metabolized too rapidly to reach the coronary microvasculature
  • CNitroglycerin acts primarily on larger vessels and the venous system rather than on small resistance vessels
  • DMicrovascular angina requires a higher dose of nitroglycerin to achieve venodilation

Correct Answer

C) Nitroglycerin acts primarily on larger vessels and the venous system rather than on small resistance vessels

Rationale

Because the pathology in microvascular angina lies in the small coronary resistance vessels rather than the larger vessels and veins that nitroglycerin primarily affects, the drug provides less consistent symptom relief in this subtype than it does in stable exertional angina.

Question 13

Why is combining a beta-blocker with a dihydropyridine calcium channel blocker a rational antianginal strategy?

  • AThe dihydropyridine increases venous capacitance, and the beta-blocker enhances this effect
  • BThe beta-blocker blunts the reflex tachycardia that the dihydropyridine's vasodilation would otherwise trigger
  • CBoth drugs act on the same hemodynamic lever, producing an additive reduction in afterload
  • DThe beta-blocker increases coronary perfusion pressure to compensate for the dihydropyridine's vasodilation

Correct Answer

B) The beta-blocker blunts the reflex tachycardia that the dihydropyridine's vasodilation would otherwise trigger

Rationale

Dihydropyridine calcium channel blockers lower afterload through arterial vasodilation, which can provoke reflex tachycardia. Pairing this agent with a beta-blocker, which contributes heart rate reduction, blunts that reflex response while the two drugs act on complementary hemodynamic levers.

Question 14

Why is the rate-pressure product a useful bedside estimate of when a patient with stable angina will reach the ischemic threshold?

  • AIt directly measures coronary blood flow during diastole
  • BIt reflects the degree of fixed coronary stenosis present in the patient
  • CIt measures the time available for coronary filling between heartbeats
  • DHeart rate and systolic blood pressure together approximate myocardial oxygen demand, which determines when demand will exceed the fixed supply

Correct Answer

D) Heart rate and systolic blood pressure together approximate myocardial oxygen demand, which determines when demand will exceed the fixed supply

Rationale

Because myocardial oxygen demand rises with heart rate and the force the heart generates against systolic pressure, the rate-pressure product serves as a simple bedside surrogate for demand, and a patient with stable angina tends to reach their symptom threshold at a reproducible value of this product.

Clinical Correlations  ·  Questions 15–18

Apply pharmacological knowledge to clinical scenarios. Each vignette presents a patient situation; the question tests mechanism of action or drug selection.

Question 15

A 58-year-old man develops chest pressure after climbing two flights of stairs. He takes a sublingual nitroglycerin tablet, and his symptoms resolve within two minutes. Which of the following mechanisms most directly explains this rapid relief?

  • AVenodilation reduces ventricular filling pressure and lowers myocardial oxygen demand
  • BArterial dilation lowers systolic wall stress and reduces afterload
  • CReduced heart rate lengthens diastole and improves coronary filling time
  • DDirect coronary vasodilation is the primary mechanism responsible for symptom relief in this setting

Correct Answer

A) Venodilation reduces ventricular filling pressure and lowers myocardial oxygen demand

Rationale

Sublingual nitroglycerin acts primarily through venodilation, which decreases ventricular filling pressure and wall stress, lowering myocardial oxygen demand. This preload-reducing effect, rather than a primary action on arterial afterload or heart rate, is the dominant mechanism behind the rapid symptom relief seen with this agent.

Question 16

A 44-year-old woman has recurrent episodes of chest pain that occur at rest, typically in the early morning. Her electrocardiogram during an episode shows transient ST-segment elevation that resolves between episodes. She is started on a beta-blocker, and her symptoms become more frequent. Which of the following best explains why this medication worsened her condition?

  • AThe beta-blocker increased myocardial oxygen demand by raising contractility
  • BBeta-2 receptor blockade removed a vasodilatory influence on coronary smooth muscle, leaving alpha-1-mediated vasoconstriction unopposed
  • CThe beta-blocker reduced coronary perfusion pressure by lowering systemic blood pressure
  • DThe beta-blocker increased nitric oxide breakdown in the coronary endothelium

Correct Answer

B) Beta-2 receptor blockade removed a vasodilatory influence on coronary smooth muscle, leaving alpha-1-mediated vasoconstriction unopposed

Rationale

This presentation describes vasospastic angina, in which beta-blockers are contraindicated. Blocking beta-2 receptors removes a normal vasodilatory counterbalance in coronary smooth muscle, allowing alpha-1-mediated vasoconstriction to predominate and worsening the underlying spasm.

Question 17

A 61-year-old woman with hypertension reports chest discomfort with exertion. An exercise stress test is positive for ischemia, but coronary angiography shows no significant obstruction in the major epicardial arteries. Sublingual nitroglycerin provides only partial relief of her symptoms. Which of the following is the most appropriate initial pharmacotherapy for this patient based on its mechanism of action?

  • AAn agent that produces venodilation to reduce ventricular filling pressure
  • BAn agent that selectively blocks beta-2 adrenergic receptors
  • CAn agent that improves dilation of small coronary resistance vessels
  • DAn agent that increases ventricular contractility to improve coronary perfusion

Correct Answer

C) An agent that improves dilation of small coronary resistance vessels

Rationale

A positive stress test with normal epicardial arteries on angiography is characteristic of microvascular angina, which results from impaired dilation of small coronary resistance vessels rather than disease of the large arteries. Agents that improve microvascular tone, such as beta-blockers and calcium channel blockers, address this underlying mechanism more directly than therapy aimed at venous or large-vessel effects.

Question 18

A 67-year-old man with stable exertional angina continues to have symptoms despite treatment with a dihydropyridine calcium channel blocker alone. His physician adds a beta-blocker to his regimen, and his symptom control improves. Which of the following best explains the rationale for adding the beta-blocker?

  • AThe beta-blocker enhances the venodilating effect of the calcium channel blocker
  • BThe beta-blocker increases coronary perfusion pressure to offset arterial dilation
  • CBoth drugs act through the same hemodynamic lever, producing a synergistic reduction in wall stress
  • DThe beta-blocker blunts the reflex tachycardia produced by the calcium channel blocker's arterial vasodilation

Correct Answer

D) The beta-blocker blunts the reflex tachycardia produced by the calcium channel blocker's arterial vasodilation

Rationale

Dihydropyridine calcium channel blockers lower afterload through arterial dilation, which can provoke reflex tachycardia that partially offsets the benefit. Adding a beta-blocker contributes heart rate reduction and blunts this reflex response, while the two agents act on complementary hemodynamic levers to produce greater overall symptom control.